Paper Details

  1. Home
  2. Paper Details

Survey of Physician Practices, Attitudes, and Knowledge Regarding Recombinant Zoster Vaccine.

Author: AndersonTara C, BeatyBrenda L, BrtnikovaMichaela, CataldiJessica R, CraneLori A, DoolingKathleen, GormanCarol, GuoAngela, HurleyLaura P, KempeAllison, LindleyMegan C, O'LearySean T

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, U.S. Gov't, P.H.S.Research funding provided by the Public Health Service (PHS).

Overview

This article discusses the updated recommendations for recombinant zoster vaccine (RZV) by the Advisory Committee on Immunization Practice (ACIP), which now includes immunocompromised adults aged ≥19 years.
Paper Details　
Original Abstract of the Article :
Herpes zoster vaccination rates remain low despite longstanding national recommendations to vaccinate immunocompetent adults aged ≥ 50 years. The Advisory Committee on Immunization Practice (ACIP) updated its recommendations for recombinant zoster vaccine (RZV) in October 2021 to include immunocompr...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261227/

データ提供：米国国立医学図書館（NLM）

Boosting Zoster Vaccination Rates: A Call to Action

Herpes zoster, commonly known as shingles, can be a painful and debilitating condition, particularly for older adults. This research examines physician practices, attitudes, and knowledge regarding the recombinant zoster vaccine (RZV). The study aims to understand the factors influencing zoster vaccination rates and identify strategies for improving vaccination coverage.

Addressing Barriers to Vaccination

The study reveals that zoster vaccination rates remain low despite longstanding recommendations. It highlights the need for greater awareness among both healthcare providers and the general public regarding the benefits of RZV. The study also emphasizes the importance of addressing misconceptions and barriers to vaccination.

Protecting Against Shingles: A Crucial Step

This research reinforces the importance of zoster vaccination, particularly for adults aged 50 years and older. The study encourages healthcare providers to actively promote vaccination and address patient concerns. It also calls for increased education and outreach efforts to raise awareness about the benefits of RZV.

Dr.Camel's Conclusion

Just as a camel needs protection from the harsh desert sun, individuals need protection from the potentially debilitating effects of shingles. This research underscores the importance of zoster vaccination, particularly for older adults. It's a reminder that preventative measures can play a vital role in safeguarding health and well-being.

Date :
  1. Date Completed 2023-03-28
  2. Date Revised 2023-04-03
Further Info :

Pubmed ID

35794307

DOI: Digital Object Identifier

PMC9261227

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.